metoprolol has been researched along with Familial Hypokalemic Periodic Paralysis in 1 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zayac, A | 1 |
Shah, R | 1 |
Shah, M | 1 |
Umar, J | 1 |
Bansal, N | 1 |
Dhamoon, A | 1 |
1 other study available for metoprolol and Familial Hypokalemic Periodic Paralysis
Article | Year |
---|---|
Thyrotoxic hypokalemic periodic paralysis.
Topics: Adult; Anti-Arrhythmia Agents; Antithyroid Agents; Humans; Hypokalemic Periodic Paralysis; Male; Met | 2016 |